Atlas Trials

Immunogenicity and Safety of Live Attenuated Influenza Vaccine (Flumist) Administered by Nasal and Sublingual Route

Clinical trial NCT01488188 · COMPLETED

Trial details

NCT number
NCT01488188
Sponsor
International Vaccine Institute
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2011-12-01
Primary completion
2013-05-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.